Literature DB >> 22841811

Pharmacokinetic change of nanoparticulate formulation "Lactosome" on multiple administrations.

Eri Hara1, Akira Makino, Kensuke Kurihara, Fumihiko Yamamoto, Eiichi Ozeki, Shunsaku Kimura.   

Abstract

Lactosome, which is a polymer micelle composed of poly(lactic acid)-b-poly(sarcosine), was applied successfully for solid tumor imaging. Lactosome is considered to escape from the reticuloendothelial system recognition, and shows prolonged in vivo blood clearance time. In vivo disposition of Lactosome, however, changed upon multiple dosages. Lactosome at the 2nd dosage was cleared from the blood stream by trapping at liver. This accelerated blood clearance (ABC) phenomenon is explained by production of anti-Lactosome IgM and IgG(3) through the immune response related with B-lymphocyte cells. The memory effect of B-lymphocyte cells lasted nearly for six months in mouse. The epitope moiety of Lactosome is concluded to be poly(sarcosine) based on the competitive inhibition assay. Since the ABC phenomenon was also reported with PEGylated liposome, nanoparticles in general may be potential in triggering the immune system.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22841811     DOI: 10.1016/j.intimp.2012.07.011

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  10 in total

1.  Factors influencing in vivo disposition of polymeric micelles on multiple administrations.

Authors:  Eri Hara; Motoki Ueda; Akira Makino; Isao Hara; Eiichi Ozeki; Shunsaku Kimura
Journal:  ACS Med Chem Lett       Date:  2014-06-18       Impact factor: 4.345

Review 2.  In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles.

Authors:  Hamed Arami; Amit Khandhar; Denny Liggitt; Kannan M Krishnan
Journal:  Chem Soc Rev       Date:  2015-09-21       Impact factor: 54.564

3.  Core-Crosslinked Polymeric Micelles: Principles, Preparation, Biomedical Applications and Clinical Translation.

Authors:  Marina Talelli; Matthias Barz; Cristianne J Rijcken; Fabian Kiessling; Wim E Hennink; Twan Lammers
Journal:  Nano Today       Date:  2015-02-01       Impact factor: 20.722

Review 4.  Solid tumor-targeting theranostic polymer nanoparticle in nuclear medicinal fields.

Authors:  Akira Makino; Shunsaku Kimura
Journal:  ScientificWorldJournal       Date:  2014-10-14

5.  Enhanced cellular uptake of lactosomes using cell-penetrating peptides.

Authors:  Akiya Akahoshi; Eiji Matsuura; Eiichi Ozeki; Hayato Matsui; Kazunori Watanabe; Takashi Ohtsuki
Journal:  Sci Technol Adv Mater       Date:  2016-06-08       Impact factor: 8.090

Review 6.  Main trends of immune effects triggered by nanomedicines in preclinical studies.

Authors:  Blanka Halamoda-Kenzaoui; Susanne Bremer-Hoffmann
Journal:  Int J Nanomedicine       Date:  2018-09-17

Review 7.  Overcoming Physiological Barriers to Nanoparticle Delivery-Are We There Yet?

Authors:  Oliver S Thomas; Wilfried Weber
Journal:  Front Bioeng Biotechnol       Date:  2019-12-17

8.  In vivo study of the immune response to bioengineered spider silk spheres.

Authors:  Tomasz Deptuch; Karolina Penderecka; Mariusz Kaczmarek; Sara Molenda; Hanna Dams-Kozlowska
Journal:  Sci Rep       Date:  2022-08-05       Impact factor: 4.996

Review 9.  Nanotechnology Advances in the Detection and Treatment of Cancer: An Overview.

Authors:  Sareh Mosleh-Shirazi; Milad Abbasi; Mohammad Reza Moaddeli; Ahmad Vaez; Mostafa Shafiee; Seyed Reza Kasaee; Ali Mohammad Amani; Saeid Hatam
Journal:  Nanotheranostics       Date:  2022-08-21

10.  Polymeric Micelle of A₃B-Type Lactosome as a Vehicle for Targeting Meningeal Dissemination.

Authors:  Kensuke Kurihara; Motoki Ueda; Isao Hara; Eiichi Ozeki; Kaori Togashi; Shunsaku Kimura
Journal:  Nanomaterials (Basel)       Date:  2018-01-31       Impact factor: 5.076

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.